| Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ... The Lancet Global Health 8 (8), e1003-e1017, 2020 | 1139 | 2020 |
| Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study AJ Kucharski, P Klepac, AJK Conlan, SM Kissler, ML Tang, H Fry, JR Gog, ... The Lancet infectious diseases 20 (10), 1151-1160, 2020 | 1045 | 2020 |
| Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection C Goujon, O Moncorgé, H Bauby, T Doyle, CC Ward, T Schaller, S Hué, ... Nature 502 (7472), 559-562, 2013 | 688 | 2013 |
| HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency T Schaller, KE Ocwieja, J Rasaiyaah, AJ Price, TL Brady, SL Roth, S Hué, ... PLoS pathogens 7 (12), e1002439, 2011 | 556 | 2011 |
| Poxvirus genomes: a phylogenetic analysis C Gubser, S Hué, P Kellam, GL Smith Journal of General Virology 85 (1), 105-117, 2004 | 507 | 2004 |
| Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ... The Lancet Global Health 8 (10), e1264-e1272, 2020 | 393 | 2020 |
| Automated analysis of phylogenetic clusters M Ragonnet-Cronin, E Hodcroft, S Hué, E Fearnhill, V Delpech, ... BMC bioinformatics 14, 1-10, 2013 | 360 | 2013 |
| Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups S Hué, D Pillay, JP Clewley, OG Pybus Proceedings of the National Academy of Sciences 102 (12), 4425-4429, 2005 | 279 | 2005 |
| Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B* 5703-restricted Gag epitope in chronic human … H Crawford, JG Prado, A Leslie, S Hué, I Honeyborne, S Reddy, ... Journal of virology 81 (15), 8346-8351, 2007 | 269 | 2007 |
| HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy S Hué, JP Clewley, PA Cane, D Pillay Aids 18 (5), 719-728, 2004 | 263 | 2004 |
| The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance RJ Gifford, TF Liu, SY Rhee, M Kiuchi, S Hue, D Pillay, RW Shafer Bioinformatics 25 (9), 1197-1198, 2009 | 224 | 2009 |
| Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections D Pao, M Fisher, S Hué, G Dean, G Murphy, PA Cane, CA Sabin, D Pillay Aids 19 (1), 85-90, 2005 | 223 | 2005 |
| Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion RK Gupta, S Hué, T Schaller, E Verschoor, D Pillay, GJ Towers PLoS pathogens 5 (5), e1000443, 2009 | 221 | 2009 |
| Disease-associated XMRV sequences are consistent with laboratory contamination S Hué, ER Gray, A Gall, A Katzourakis, CP Tan, CJ Houldcroft, S McLaren, ... Retrovirology 7, 1-10, 2010 | 212 | 2010 |
| Persistence of HIV-1 transmitted drug resistance mutations H Castro, D Pillay, P Cane, D Asboe, V Cambiano, A Phillips, DT Dunn, ... The Journal of infectious diseases 208 (9), 1459-1463, 2013 | 126 | 2013 |
| Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals S Hué, RJ Gifford, D Dunn, E Fernhill, D Pillay Journal of virology 83 (6), 2645-2654, 2009 | 112 | 2009 |
| Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study Y Chen, N Li, J Lourenço, L Wang, B Cazelles, L Dong, B Li, Y Liu, M Jit, ... The Lancet infectious diseases 22 (5), 657-667, 2022 | 107 | 2022 |
| An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins T Schaller, S Hué, GJ Towers Journal of virology 81 (21), 11713-11721, 2007 | 97 | 2007 |
| HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef D Sauter, S Hué, SJ Petit, JC Plantier, GJ Towers, F Kirchhoff, RK Gupta Retrovirology 8, 1-9, 2011 | 90 | 2011 |
| Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom A Tostevin, E White, D Dunn, S Croxford, V Delpech, I Williams, D Asboe, ... HIV medicine 18 (3), 204-213, 2017 | 86 | 2017 |
